Skyepharma Names CFO and Executive Director

August 23, 2013
Pharmaceutical Technology Editors

Andrew Derodra will join Skyepharma in the fourth quarter of 2013.

The drug-delivery company Skypharma has appointed Andrew Derodra as CFO and an executive director, effective in the fourth quarter of 2013.

Derodra joins Skyepharma from Tate & Lyle, where he had been group vice-president, finance and control, since 2011. He has spent 23 years working in senior finance roles for various companies, including SABMiller, Diageo, British Airways, and Reed Elsevier.

Source: Skypharma